C12Y 599/01
Enzymes: other isomerases: other isomerases
Official title: Other isomerases (5.99.1)
C12Y599/01 (Enzymes: other isomerases: other isomerases) appears on 56 US grants and 68 published applications in this corpus.
Search patents in C12Y- Granted patents
- 56
- Published applications
- 68
- Assignees
- 44
- Inventors
- 166
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 3 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 3 | 3 |
| 2013 | 1 | 6 |
| 2014 | 1 | 2 |
| 2015 | 1 | 5 |
| 2016 | 1 | 4 |
| 2017 | 0 | 2 |
| 2018 | 2 | 6 |
| 2019 | 1 | 3 |
| 2020 | 6 | 5 |
| 2021 | 5 | 5 |
| 2022 | 2 | 1 |
| 2023 | 2 | 3 |
| 2024 | 1 | 5 |
| 2025 | 2 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for inducing targeted meiotic recombinations1 Sep 2026US 12,723,267 B2Centre National De La Recherche Scientifique
- Enzymes and systems for synthesizing DNA24 Jun 2025US 12,338,470 B2Iridia, Inc.
- Modified helicases18 Mar 2025US 12,252,717 B2Oxford Nanopore Technologies PLC
- Methods for reactivating genes on the inactive X chromosome27 Feb 2024US 11,912,994 B2The General Hospital Corporation
- Enzymes and systems for synthesizing DNA23 May 2023US 11,655,465 B1Iridia, Inc.
- Compositions and methods for treatment or prventative treatment of cancer including triple negative breast cancer and/or lung cancer24 Sep 2026US 2026/0284165 A1The Medical College of Wisconsin, Inc.
- Method to generate supercoiled circular dna in vitro19 Feb 2026US 2026/0049341 A1University of Maryland, Baltimore County
- Use of fana antisense oligonucleotides for the prevention and management of huanglongbing and zebra chip diseases23 Jan 2025US 2025/0027079 A1
- Modified helicases19 Dec 2024US 2024/0417704 A1Oxford Nanopore Technologies PLC
- Anti-hiv-1 recombinant hiv-1 derived topoisomerase ii beta kinase as an immunogen for hiv vaccine24 Oct 2024US 2024/0350618 A1University of Hyderabad
Most cited
By later US patents
- Methods and applications for efficient genetic suppressor elements101US 5,217,889 A1993
- Methods and applications for efficient genetic suppressor elements55US 5,811,234 AThe Board of Trustees of the University of Illinois · 1998
- Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)25US 10,286,052 B2Immatics Biotechnologies GmbH · 2019
- Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)24US 10,064,924 B2Immatics Biotechnologies GmbH · 2018
- Genes and genetic elements associated with sensitivity to chemotherapeutic drugs15US 5,665,550 ABoard of Trustees of the University of Illinois-Urbana · 1997